Intrepid Potash, Inc. IPI
At closeNov 3, 2026, 4:58 PM EST
After hours · Nov 3, 4:58 PM ET
- YTD
- +10.89%
- 1 year
- +17.01%
- Market cap
- 413.79M
- Revenue (ttm)
- 206.36M
- Profit margin
- -20.88%
- EPS (ttm)
- 0.95
- Shares out
- 13.16M
- P/E ratio
- 32.37
- Forward P/E
- -131.29
- YTD return
- +10.89%
- 1-year return
- +17.01%
- Volume
- 190.93K
- Avg volume
- 200.03K
- Open
- 30.95
- Previous close
- 30.99
- Day's range
- 30.64 – 31.23
- 52-week range
- 22.55 – 50.34
- Beta
- 2.19
- Price target
- 19.00 (-38.2%)
2Y +4.14 (+15.49%)
Key statistics
- Enterprise value
- 238.86M
- PEG ratio
- 0.00
- Price / sales
- 1.42
- Price / book
- 0.39
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 6.00%
- Free cash flow
- -1.10M
- Total cash
- 40.01M
- Total debt
- 2.94M
- Return on equity
- -6.15%
- Short % of float
- 2.96%
- 50-day average
- 25.82
- 200-day average
- 23.72
Analyst view
- Strong buy0
- Buy0
- Hold0
- Sell2
- Strong sell0
Next earnings
Consensus EPS estimate -0.05298.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2024 | Sep 1, 2024 | 0.11 | -0.14 | -0.25 | -227.27% |
| Aug 5, 2024 | Jun 1, 2024 | 0.02 | 0.00 | — | — |
| May 8, 2024 | Mar 1, 2024 | 0.04 | -0.14 | -0.18 | -450.00% |
| Mar 6, 2024 | Dec 1, 2023 | -0.21 | -0.41 | -0.20 | -95.24% |
| Nov 8, 2023 | Sep 1, 2023 | -0.02 | -0.53 | -0.51 | -2,550.00% |
| Aug 2, 2023 | Jun 1, 2023 | 0.45 | 0.33 | -0.12 | -26.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2024 | UBS | main | Sell | Sell |
| May 10, 2024 | BMO Capital | main | Market Perform | Market Perform |
| Nov 10, 2023 | BMO Capital | main | Market Perform | Market Perform |
| May 5, 2023 | BMO Capital | main | — | Market Perform |
| Jan 11, 2023 | UBS | main | — | Sell |
| Nov 4, 2022 | BMO Capital | main | — | Market Perform |
About Intrepid Potash, Inc.
Intrepid Potash, Inc., together with its subsidiaries, engages in the extraction and production of the potash in the United States and internationally. It operates through three segments: Potash, Trio, and Oilfield Solutions. The company offers muriate of potash for various markets, such as agricultural market as a fertilizer input; the industrial market as a component in drilling and fracturing fluids for oil and gas wells, as well as an input to other industrial processes; and the animal feed market as a nutrient supplement. It also provides Trio, a specialty fertilizer that delivers potassium, sulfate, and magnesium in a single particle; water for oil and gas services industry; salt for various markets, including animal feed, industrial applications, pool salt, and the treatment of roads and walkways for ice melting or to manage road conditions; magnesium chloride for use as a road treatment agent for deicing and dedusting; brines for use in oil and gas industry to support well workover and completion activities; and metal recovery salts. Intrepid Potash, Inc. was founded in 1999 and is based in Denver, Colorado.
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Country
- United States
- Website
- intrepidpotash.com
News
Intrepid Potash Q3 Adj. EPS $0.14 Misses $0.25 Estimate, Sales $51.034M Beat $50.810M Estimate 
Intrepid Announces Third Quarter 2026 Results 
Intrepid Potash Selected for $139M USDA Grant for SOP Project 
Intrepid Potash (IPI) Reports Next Week: Wall Street Expects Earnings Growth 
U.S. Department Of Agriculture Selects Intrepid Potash's Sulfate Of Potash Project For ~$139M In Proposed Matching Financing For Construction Of Production Site In New Mexico 
Intrepid Selected for USDA Matching Grant Award to Support Carlsbad Sulfate of Potash Project 
Intrepid Announces Date for Third Quarter 2026 Earnings Release 
Reviewing Intrepid Potash (NYSE:IPI) & Minerals Technologies (NYSE:MTX) 
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell 
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell
Your note
Sign in to keep a note on IPI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CRUTCHFIELD KEVIN S | Chief Executive Officer | Stock Award(Grant) | Dec 1, 2024 | 63,892 |
| ELLIOTT CHRIS A | Director | Stock Award(Grant) | Sep 23, 2024 | 44,397 |
| HARVEY HUGH E JR | Director | Stock Award(Grant) | Sep 23, 2024 | 4,437 |
| INGOLD CRIS | Officer | Stock Award(Grant) | Apr 11, 2024 | 11,172 |
| JORNAYVAZ ROBERT P III | Chief Executive Officer | Sale | Mar 21, 2024 | 0 |
| LANCASTER LORI A. | Director | Stock Award(Grant) | Sep 23, 2024 | 13,052 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Gate City Capital Management, LLC | 6.36% | 837,570 | 18.69M | Sep 29, 2024 |
| Blackrock Inc. | 6.36% | 837,423 | 18.69M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 5.54% | 729,802 | 16.29M | Sep 29, 2024 |
| First Eagle Investment Management, LLC | 4.78% | 629,470 | 14.05M | Sep 29, 2024 |
| Azarias Capital Management, LP | 4.65% | 612,018 | 13.66M | Sep 29, 2024 |
| Vanguard Group Inc | 4.63% | 609,770 | 13.61M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| First Eagle Small Opportunity Fund | 4.21% | 553,861 | 12.36M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.68% | 352,625 | 7.87M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.10% | 276,317 | 6.17M | Oct 30, 2024 |
| Avantis U.S. Small Cap Value ETF | 1.16% | 153,256 | 3.42M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.05% | 138,492 | 3.09M | Sep 29, 2024 |
| DFA U.S. Small Cap Value Series | 1.00% | 131,916 | 2.94M | Jul 30, 2024 |